#aard

2 weeks ago

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome Aardvark Therapeutics (Nasdaq: AARD) has voluntarily paused the Phase 3 HERO trial (NCT06828861) and its open-label extension (NCT07197034) for ARD-101 in Prader-Willi syndrome due to reversible cardiac observations at above-target doses observed in a healthy volunteer study.The company paused enrollment and dosing while conducting a comprehensive data review, will collaborate with the FDA and experts, and now expects to delay topline HERO data previously planned for Q3 2026, with further guidance expected in Q2 2026.

#AARD Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

Arie in Wonderland

@ariannenotenboom.bsky.social

3 months ago

Path of Light - 16 nov 2025

#way #illumination #aard #walk #wisdom #beestje #waaiboom #dividivi #schiermonnikoog #veni #vidi #amici

#fotodagboek #photodiary #since2009

6 0 1 0

StockTitan

@stocktitan.net

4 months ago

Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates Aardvark Therapeutics (Nasdaq: AARD) reported Q3 2025 results and pipeline updates on Nov 13, 2025. The company disclosed $126.4 million in cash, cash equivalents, and short-term investments as of Sept 30, 2025, which it expects will fund operations into 2027. Aardvark aligned with the FDA to lower the HERO Phase 3 ARD-101 trial minimum age from 13 to 10 years and started the HERO Open Label Extension with sites in Australia. Preclinical data for oral ARD-201 showed glucose control, lean mass preservation, ~19% weight reduction in mice, and ~30% weight loss when combined with low-dose tirzepatide. Topline HERO data expected Q3 2026; POWER interim data expected 2H 2026.

#AARD Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025 New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today’s obesity treatment landscape Preclinical and clinical data demonstrates the potential of ARD-201 to

#AARD Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

𝐌𝐚𝐠𝐢𝐜 𝐒𝐭𝐮𝐝𝐢𝐨𝐬 ✨ 𝐵𝑦 𝐴𝑙𝑖𝑐𝑒

@magicstvdios.bsky.social

4 months ago

The Witcher signs!

For the concert ✨
10th anniversary of The Witcher 3: Wild Hunt

#yennefer #geraltofrivia #thewitchernetflix #thewitcher #ciri #Aard #Axii #quen #igni #yrden #witchersigns #nailart #altnails #gaming #gamernails #gamer #magicstudios #thewitcherconcert

0 1 0 0

StockTitan

@stocktitan.net

5 months ago

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome Aardvark Therapeutics (Nasdaq: AARD) announced FDA alignment on a protocol amendment to its Phase 3 HERO trial of ARD-101 for hyperphagia in Prader-Willi syndrome (PWS).The amendment lowers minimum enrollment age from 13 to 10 years, broadening the eligible patient population. Management cited community support and historical data suggesting younger patients may benefit more from early intervention. The company reaffirmed a planned topline data readout in Q3 2026.

#AARD Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

Aardvark's New Obesity Drug Shows Promise in Preventing Post-GLP-1 Weight Rebound Novel obesity drug ARD-201 demonstrates potential to prevent weight regain after GLP-1 discontinuation. Company expands rare disease trial to younger patients. $141.8M funds operations to 2027. Learn more.

#AARD Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

7 months ago

Leading Indicators, Wednesday July 30, 2025 – Crystal Equity Research

Small-cap stocks in new downtrend with AROON Oscillator, Wed Jul 30th - #RPD #QSI #PHLT #OM #NWBI #MBIN #LFCR #KARO #IBCP #HAFC #SAGE #GAIN #FCBC #EVGN #DIBS #CERS #BEAT #AARD #VFS #TDOC #SCL #TBRG - More: crystalequityresearch.com/leading-indi... - #smallcap

1 0 0 0

Coré-Perséphone 🏳️‍🌈🏳️‍⚧️🏴‍☠️

@petitecore.bsky.social

8 months ago

Un frèriste quand même, il avance juste à visage masqué, sous taqîya.
Et bien les anti-trans comme Audrey #Aard qui sont des tenants de l'existence de l'autogynéphilie c'est un peu pareil. Les femmes trans très féminines prouvent ainsi leur autogynéphilie. Et celles qui ne sont pas féminines sont

19 0 1 0

StockTitan

@stocktitan.net

8 months ago

Promising Phase 2 Results: Aardvark's PWS Drug ARD-101 Shows Reduced Hyperphagia, Phase 3 Trial Enrolling Latest Phase 2 data reveals ARD-101's impact on hyperphagia in Prader-Willi syndrome patients. Learn about ongoing Phase 3 HERO trial enrollment details.

#AARD Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

StockTitan

@stocktitan.net

10 months ago

Aardvark's First Post-IPO Earnings Show $151M War Chest for Rare Disease Drug Development Fresh from $98M IPO, Aardvark advances Phase 3 trial for rare metabolic disease treatment. See detailed financials and development timeline for ARD-101. Get insights.

#AARD Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

www.stocktitan.net/news/AARD/aardvark-thera...

0 0 0 0

Araety-Kintaey 🦨🐺

@stinkbutt.info

11 months ago

Yeen Blue Merle COllie Folf Dogg Mix, sitting and concenplating

#indiedev #gamedev #gamedevelopers #gymrats #gymrat #nude #yeen #butter #yeenbutter #stripedhyena #aardwold #aard #wolf #fox #fox #god #dog #dogg #godd #spirituality #spiritology #gametheory #compsci #art #myart #artistontwitter

3 0 0 0

Araety-Kintaey 🦨🐺

@stinkbutt.info

11 months ago

View Gallery Post ID 20 by missionforce-yeenconomics - by missionforce-yeenconomics View Gallery Post ID 20 by missionforce-yeenconomics

miaedscore.online/gallery/view...

The game will be released this year; tht title of the game is our screen name.

#stinky #stimky #musk #musky #indiedev #gamedev #rust #surtlang #rubylang #crystallang #crystal #internet #art #stink #yeen #aard

3 0 0 0

Araety-Kintaey 🦨🐺

@stinkbutt.info

11 months ago

We're the CEOs of the scene/furry

Our question to our cult: ARE YOU BIG & hung ENOUGH?

The game will be released this year; tht title of the game is our screen name.

#stinky #stimky #musk #musky #indiedev #gamedev #rust #surtlang #rubylang #crystallang #crystal #internet #art #stink #yeen #aard